Patent details

Basic Information

Publication number:

EP1294715

PCT Application Number:

PCT/US/2001/020706

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019523042

PCT Publication Number:

WO/2002/002552

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUINAZOLINE DITOSYLATE SALT COMPOUNDS

French Title of Invention:

COMPOSES DITOSYLATES DE QUINAZOLINE

German Title of Invention:

DITOSYLATSALZE VON CHINAZOLINVERBINDUNGEN

SPC Number:

Dates

Filing date:

28/06/2001

Grant date:

14/02/2007

EP Publication Date:

14/02/2007

PCT Publication Date:

10/01/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/03/2003

EP B1 Publication Date:

14/02/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/06/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/12/2015

 

 

Name:

NOVARTIS AG

Address:

LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

History of Owners

From:

17/12/2015

To:

17/12/2015

Name:

LEO OSPREY LIMITED

Address:

980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)

From:

03/04/2015

To:

03/04/2015

Name:

GLAXO GROUP LIMITED

Address:

980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)

From:

03/04/2015

To:

16/12/2015

Name:

GLAXOSMITHKLINE LLC

Address:

CORPORATION SERVICE COMPANY, 2711 CENTERVILLE ROAD, S. 400, WILMINGTON, DELAWARE 19808, United States (US)

From:

28/06/2001

To:

02/04/2015

Name:

GLAXO GROUP LIMITED

Address:

Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Agent

1

Name:

OFFICE FREYLINGER S.A.

From:

21/03/2007

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

2

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

03/04/2015

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

ROSCHANGAR Frank, GlaxoSmithKline

Address:

United States (US)

2

Name:

SACCHETTI Mark J., GlaxoSmithKline

Address:

United States (US)

3

Name:

MCCLURE Michael S., GlaxoSmithKline

Address:

United States (US)

4

Name:

OSTERHOUT Martin H., GlaxoSmithKline

Address:

United States (US)

Priority

1

Priority Number:

215508 P

Priority Date:

30/06/2000

Priority Country:

United States (US)

2

Priority Number:

271845 P

Priority Date:

27/02/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 405/04;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/06/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages